US and Israel Fund $20M in Health and Tech Innovation

The Israel-US Binational Industrial Research and Development Foundation just approved $7.5 million in grants for seven groundbreaking partnerships, with private companies adding another $12.5 million to bring the total investment to $20 million. These aren't pie-in-the-sky ideas but practical projects already moving from labs to real-world applications.

The partnerships bring together companies from both countries to solve problems that affect everyday lives. One collaboration is developing non-invasive tumor screening for cats and better diagnostic tools for dogs, potentially saving pet owners from expensive surgeries and giving veterinarians better tools to catch cancer early.

Another project is creating a genome-wide prenatal test that can detect rare genetic disorders before birth, giving parents crucial information earlier in pregnancy. A third partnership is working on cell therapy for progressive multiple sclerosis, offering hope to patients whose condition continues to worsen despite current treatments.

The projects also address pressing needs beyond healthcare. One team is building AI-powered smart spraying systems that target weeds precisely, reducing the amount of chemicals farmers need to use. Another is developing cybersecurity protection for critical infrastructure like power grids and water systems, which have become increasingly vulnerable to cyberattacks.

The BIRD Foundation has been connecting American and Israeli innovators for 49 years, supporting more than 1,200 projects in that time. The foundation invests about $465 million and helps companies find the right partners across borders, then shares the financial risk of developing new technologies.

The Ripple Effect

These seven projects represent more than just scientific advancement. When companies from different countries work together, they combine unique strengths: Israeli innovation and American scale. Previous BIRD-supported projects have generated more than $10 billion in revenue, creating jobs and bringing new products to market that improve lives around the world.

Dr. Alon Stopel, who co-chairs BIRD's Board of Governors, noted that the partnerships demonstrate how technological cooperation creates solutions for complex global challenges. Mike Molnar, his co-chair from the National Institute of Standards and Technology, emphasized how sharing development risks enables companies to advance critical technologies they might not tackle alone.

The next funding cycle opens in November, with approvals expected in March 2027. For companies with big ideas and the willingness to work across borders, the path to turning innovation into impact just got clearer.